Products

Golimumab

Golimumab belongs to a class of biologic medications known as tissue necrosis factor alpha (TNF-α)-blockers. Excess amounts of TNF-α causes the immune system to attack healthy cells in the target area such as gastrointestinal (GI) tract or joints, resulting in inflammation. Golimumab binds to TNF-α, blocking its action to help improve symptoms.

Nufactor carries the following golimumab brands:

Brand (Manufacturer)
FDA-approved indication(s) [abbreviated]
Brand (Manufacturer):
FDA-approved indication(s) [abbreviated]:
  • Ankylosing spondylitis (adult)
  • Psoriatic arthritis (2+ years old)
  • Rheumatoid arthritis (RA) in combination with methotrexate (adult)
  • Polyarticular Juvenile Idiopathic Arthritis (pJIA) (2+ years old)
Brand (Manufacturer):
FDA-approved indication(s) [abbreviated]:
  • Ankylosing spondylitis (adult)
  • Psoriatic arthritis alone or in combination with methotrexate (adult)
  • Rheumatoid arthritis (RA), in combination with methotrexate (adult)
  • Ulcerative colitis (UC) (adult)

Become a Nufactor Patient & Refer a Patient

Talk with us today about how to Become a Nufactor Patient and how to Refer a Patient. Call us at (800) 323-6832 and we will be more than happy to help you through the process.